Abstract
Patients with type 2 diabetes are at enhanced risk for macro- and microvascular complications. Albuminuria and/or reduced kidney function further enhances the vascular risk. We initiated the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE). Aliskiren, a novel direct renin inhibitor, which lowers plasma renin activity, may thereby provide greater cardio-renal protection compared with angiotensin converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) alone. ALTITUDE is a randomized, double-blind, placebo-controlled study in high risk type 2 diabetic patients receiving aliskiren 300 mg once daily or placebo added to recommended cardio-renal protective treatment including ACEi or ARB, but not both. The number of patients randomized was 8606. Baseline characteristics (median, IQR) are: age 65 (58, 72) years, male 68%, BMI 29.1 (25.7, 32.2) kg/m(2), cardiovascular disease 47.9%, blood pressure 134.7 (126, 150)/74.3 (67, 81) mmHg, HbA(1c) 7.5 (6.6, 8.6)%, LDL-cholesterol 2.4 (1.9, 3.0) mmol/L, haemoglobin 130 (119, 143) g/L, serum creatinine 115 (91, 137) µmol/L, eGFR 51.7 (42, 65) ml/min per 1.73 m(2), geometric mean UACR 198.9 (52, 2886) mg/g and frequency of micro/macroalbuminuria 25.7% a...Continue Reading
References
May 28, 1983·Lancet·H H ParvingP A Svendsen
Jul 1, 1995·Diabetes·F S NielsenH H Parving
May 1, 1994·Diabetologia·P RossingH H Parving
Mar 13, 1999·Annals of Internal Medicine·A S LeveyD Roth
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Sep 22, 2001·The New England Journal of Medicine·H H ParvingUNKNOWN Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group
Mar 8, 2002·Hypertension·Roberto SegaGiuseppe Mancia
May 20, 2004·Kidney International·Dick de ZeeuwBarry M Brenner
Aug 11, 2004·Circulation·Dick de ZeeuwBarry M Brenner
Sep 24, 2004·The New England Journal of Medicine·Nagesh S AnavekarMarc A Pfeffer
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Oct 24, 2006·Lancet·Jan A StaessenTom Richart
Feb 8, 2008·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Mar 14, 2008·Kidney International·F PerssonH-H Parving
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
Jun 6, 2008·The New England Journal of Medicine·Hans-Henrik ParvingUNKNOWN AVOID Study Investigators
Jun 19, 2008·Circulation·Naomi D L FisherNorman K Hollenberg
Jan 16, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hans-Henrik ParvingMarc A Pfeffer
Jan 21, 2009·Circulation·Scott D SolomonUNKNOWN Aliskiren in Left Ventricular Hypertrophy (ALLAY) Trial Investigators
Jul 10, 2009·Diabetes Care·Frederik PerssonHans-Henrik Parving
Mar 6, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·David L Feldman
May 19, 2010·Diabetologia·F PerssonH-H Parving
Sep 24, 2010·Kidney International·János Peti-Peterdi
Oct 12, 2010·The New England Journal of Medicine·Sophia ZoungasUNKNOWN ADVANCE Collaborative Group
Dec 21, 2010·American Heart Journal·David PreissJohn J McMurray
Feb 15, 2011·European Heart Journal·Scott D SolomonUNKNOWN Aliskiren Study in Post-MI Patients to Reduce Remodeling (ASPIRE) Investigators
Mar 5, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Henrik ReinhardPeter K Jacobsen
Mar 26, 2011·Journal of the American Society of Nephrology : JASN·Lisa R Stow, Michelle L Gumz
Jul 2, 2011·Journal of the American Society of Nephrology : JASN·Roland E SchmiederUNKNOWN ONTARGET Investigators
Jul 28, 2011·BMJ : British Medical Journal·Rémy BoussageonCatherine Cornu
Jul 28, 2011·BMJ : British Medical Journal·David Preiss, Kausik K Ray
Citations
May 24, 2012·Heart and Vessels·Masanori AbeMasayoshi Soma
Dec 19, 2012·Nature Reviews. Nephrology·Hiddo J Lambers HeerspinkGerjan J Navis
Oct 31, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hiddo J Lambers HeerspinkDick de Zeeuw
Jun 6, 2013·Current Opinion in Cardiology·Susanne B NicholasKeith C Norris
Dec 13, 2012·Hypertension·Norihito MoniwaCarlos M Ferrario
Jun 13, 2013·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Sławomir LizakowskiBolesław Rutkowski
May 16, 2013·PloS One·Cheuk-Chun SzetoPhilip Kam-Tao Li
Mar 9, 2013·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Damien Noone, Christoph Licht
Jul 3, 2013·International Journal of Nephrology·Masako FurukawaYasuhiko Tomino
Jan 28, 2014·International Heart Journal·Yuichi OzakiTakashi Akasaka
Dec 12, 2012·Cardiovascular Drugs and Therapy·Thomas G von Lueder, Henry Krum
Jun 28, 2014·Current Hypertension Reports·David Parra, Augustus Hough
Aug 12, 2014·Advances in Medical Sciences·Marcin RenkeBolesław Rutkowski
Jan 23, 2013·Current Atherosclerosis Reports·Chiara Recarti, Thomas Unger
Mar 8, 2014·Advances in Chronic Kidney Disease·Frederik Persson, Peter Rossing
Apr 23, 2013·Maturitas·Georgia ArgyrakopoulouChristodoulos Stefanadis
Jan 18, 2013·Kidney International·David C Wheeler, Gavin J Becker
Dec 1, 2012·Kidney International Supplements
May 21, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Sandra J TalerRaymond R Townsend
Sep 6, 2012·The Journal of Clinical Hypertension·Lawrence R Krakoff
Mar 21, 2012·European Journal of Heart Failure·John J V McMurrayHenry Krum
Aug 7, 2012·The Journal of Clinical Hypertension·Tomohiko KanaokaSatoshi Umemura
Apr 2, 2013·The Canadian Journal of Cardiology·Rhian M Touyz
Mar 17, 2015·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Patrick Blin
Dec 3, 2014·Drug Discovery Today·Meng LvQianbin Li
Jan 16, 2015·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Sylwia Magiera, Jacek Kusa
Jun 8, 2012·Journal of Pharmacological Sciences·Bai LeiAkira Nishiyama
Oct 20, 2012·Journal of Pharmacological Sciences·Paulo Caleb Junior Lima SantosAlexandre Costa Pereira
May 6, 2015·PloS One·Ping LiWenying Yang
Jun 24, 2016·Diabetes, Obesity & Metabolism·N G C van der SandeH L J Heerspink
Oct 25, 2013·Journal of Human Hypertension·J DeiuliisS Rajagopalan
Dec 12, 2012·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Men-Tai WuChien-Te Lee
Mar 8, 2013·European Journal of Preventive Cardiology·P A SminkH J Lambers Heerspink
Apr 1, 2018·Diabetes, Obesity & Metabolism·Hiddo J L HeerspinkDick de Zeeuw
Feb 28, 2020·The Cochrane Database of Systematic Reviews·Meaghan LunneyPietro Ravani
Nov 2, 2016·Journal of the American Society of Nephrology : JASN·Tobias F KröpelinHiddo J L Heerspink
Jun 1, 2016·European Stroke Journal·Azmil H Abdul-RahimJohn Jv McMurray
Feb 12, 2021·BMJ : British Medical Journal·Ali AlbasriUNKNOWN STRATIFY investigators